Imagine surviving cancer and then getting a new chronic disease as a side effect of treatment. That’s reality for cancer survivors who develop the limb-swelling complication lymphedema, which is caused by a buildup of lymphatic fluid. But as medical device maker ImpediMed points out in its first major consumer-facing campaign, testing and early detection can […]

Once-a-day treatment with oral ANVS401 was found to significantly improve motor skills among Parkinson’s disease patients in a Phase 2a clinical trial. Annovis Bio, the company developing ANVS401, is now planning to meet with the U.S. Food and Drug Administration (FDA) to discuss possibly initiating larger Phase 3 studies. “We are thrilled by these improvements in motor […]

Cartesian Therapeutics focuses on RNA-based cell therapies. In August, for example, the company announced successful results from a Phase I trial of an RNA-based treatment called Descartes-08 for the autoimmune disorder myasthenia gravis. Murat Kalayoglu, MD, PhD, president and CEO describes this treatment as “an autologous T-cell product engineered with RNA to express a chimeric […]